LifePlan Investment Advisors Inc. Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

LifePlan Investment Advisors Inc. lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 428 shares of the healthcare conglomerate’s stock after purchasing an additional 49 shares during the quarter. LifePlan Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $217,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of the stock. Lionshead Wealth Management LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $361,000. Investment Management Corp of Ontario increased its holdings in UnitedHealth Group by 49.3% in the 4th quarter. Investment Management Corp of Ontario now owns 45,553 shares of the healthcare conglomerate’s stock worth $23,043,000 after buying an additional 15,032 shares in the last quarter. Investor s Fiduciary Advisor Network LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $478,000. Janus Henderson Group PLC increased its holdings in UnitedHealth Group by 11.1% in the 4th quarter. Janus Henderson Group PLC now owns 5,507,957 shares of the healthcare conglomerate’s stock worth $2,786,393,000 after buying an additional 549,658 shares in the last quarter. Finally, KKM Financial LLC grew its stake in shares of UnitedHealth Group by 3.9% during the 4th quarter. KKM Financial LLC now owns 5,439 shares of the healthcare conglomerate’s stock valued at $2,751,000 after purchasing an additional 206 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Mizuho boosted their price target on UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Truist Financial cut their price target on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research note on Monday, April 21st. Barclays cut their price target on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Wells Fargo & Company cut their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 22nd. Four equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $596.86.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $380.72 on Monday. The stock’s fifty day moving average is $488.01 and its 200 day moving average is $522.04. UnitedHealth Group Incorporated has a fifty-two week low of $378.54 and a fifty-two week high of $630.73. The firm has a market capitalization of $345.37 billion, a PE ratio of 24.56, a PEG ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the company posted $6.91 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.